Markets

Cellectis (CLLS) Catches Eye: Stock Adds 18.5% in Session

Cellectis S.A.CLLS was a big mover last session, as its shares rose over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday's rally breaks the recent trend for the company, as the stock is now trading above the volatile price range of $23.67 to $27.55 in the past one-month time frame.

Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cellectis currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Another favorably ranked biomedical stock is Actelion Ltd. ALIOF with a Zacks Rank #1 (Strong Buy).

Is CLLS going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ACTELION LTD (ALIOF): Free Stock Analysis Report

CELLECTIS-ADR (CLLS): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CLLS ALIOF

Other Topics

Investing Stocks